Literature DB >> 28677999

Effectiveness of Black Mulberry Molasses in Prevention of Radiotherapy-Induced Oral Mucositis: A Randomized Controlled Study in Head and Neck Cancer Patients.

Melike Demir Doğan1, Gulbeyaz Can2, Rasim Meral3.   

Abstract

OBJECTIVES: Radiation-induced oral mucositis is one of the problems experienced by 70%-80% of patients receiving radiation therapy (RT). This randomized controlled trial assessed the effectiveness of black mulberry molasses in the prevention of oral mucositis in head and neck cancer patients receiving RT. INTERVENTIONS AND OUTCOME MEASURES: Eighty head and neck cancer patients scheduled to undergo RT to the oropharyngeal mucosa were randomly assigned to receive RT (42) or RT plus mulberry molasses (38). The research data were collected with a Patient Description Form, Common Terminology Criteria for Adverse Events, version 4.0, an Oral Assessment Guide, and the University of Washington Quality of Life Assessment Questionnaire.
RESULTS: The incidence and severity of oral mucositis were lower in the black mulberry molasses group. However, black mulberry molasses usage was an only independent and significant factor in prevention of mucositis [HR 0.63 (%95 GI 0.40-0.98)]. There were no differences between the quality of life scores of experimental and control groups.
CONCLUSIONS: This randomized controlled study showed that black mulberry molasses usage is an effective intervention in the prevention of the radiation-induced mucositis of head and neck cancer patients. However, to confirm these results, further studies are needed.

Entities:  

Keywords:  head and neck cancer; mucositis; mulberry molasses; radiation therapy

Mesh:

Substances:

Year:  2017        PMID: 28677999     DOI: 10.1089/acm.2016.0425

Source DB:  PubMed          Journal:  J Altern Complement Med        ISSN: 1075-5535            Impact factor:   2.579


  7 in total

1.  Clinical applicability of natural products for prevention and treatment of oral mucositis: a systematic review and meta-analysis.

Authors:  Ingrid Carla Guedes da Silva Lima; Laura de Fátima Souto Maior; Luiz Alcino Monteiro Gueiros; Jair Carneiro Leão; Jane Sheila Higino; Alessandra Albuquerque Tavares Carvalho
Journal:  Clin Oral Investig       Date:  2021-01-07       Impact factor: 3.573

2.  Biofortified Whey/Deglycosylated Whey and Chickpea Protein Matrices: Functional Enrichment by Black Mulberry Polyphenols.

Authors:  Adem Ozleyen; Zeynep Ozlem Cinar; Sercan Karav; Ayse Bayraktar; Aysenur Arslan; H Mehmet Kayili; Bekir Salih; Tugba Boyunegmez Tumer
Journal:  Plant Foods Hum Nutr       Date:  2021-11-30       Impact factor: 3.921

3.  Evaluation of the efficacy of the anti-ulcer oral mucosal protective agent RADoralex® in the prevention and treatment of radiation-induced oral mucosal reactions induced during treatment of nasopharyngeal carcinoma.

Authors:  Jun Yin; Jirui Xie; Jiawei Lin; Chengyin Weng; Shun Lu; Peng Xu; Shuo Zhang; Cheng Luo; Yecai Huang; Lu Li; Jinyi Lang; Mei Feng
Journal:  Cancer Biol Ther       Date:  2022-01-06       Impact factor: 4.742

Review 4.  Medicinal plants used for the treatment of mucositis induced by oncotherapy: a systematic review.

Authors:  Patrícia Leão Castillo Eubank; Lucas Guimaraes Abreu; Ivana Povoa Violante; Luiz Evaristo Ricci Volpato
Journal:  Support Care Cancer       Date:  2021-05-14       Impact factor: 3.603

Review 5.  Natural Product Interventions for Chemotherapy and Radiotherapy-Induced Side Effects.

Authors:  Qing-Yu Zhang; Fei-Xuan Wang; Ke-Ke Jia; Ling-Dong Kong
Journal:  Front Pharmacol       Date:  2018-11-06       Impact factor: 5.810

Review 6.  Status of Treatment and Prophylaxis for Radiation-Induced Oral Mucositis in Patients With Head and Neck Cancer.

Authors:  Shiyu Liu; Qin Zhao; Zhuangzhuang Zheng; Zijing Liu; Lingbin Meng; Lihua Dong; Xin Jiang
Journal:  Front Oncol       Date:  2021-03-18       Impact factor: 6.244

Review 7.  Narrative review of the management of oral mucositis during chemoradiation for head and neck cancer.

Authors:  Lauren F Judge; Mark K Farrugia; Anurag K Singh
Journal:  Ann Transl Med       Date:  2021-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.